Morphine sulfate
- Product NDC
- 0228-3502
- 11-digit product format
- 002283502
- Labeler code
- 0228
- Product ID
- 0228-3502_30e79184-ceeb-4a0b-931f-7358f556987d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine sulfate
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- NDA020616
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2011-11-11
- Marketing end
- 2023-02-28
- Substance
- MORPHINE SULFATE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0228-3502-06 | 00228350206 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3502-06) | 2011-11-11 | 0000-00-00 | No | No | Current |
| 0228-3502-11 | 00228350211 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3502-11) | 2011-11-11 | 0000-00-00 | No | No | Current |